Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects.

Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects. Abstract Text:

    di chenDi Chen,michael frezzaMichael Frezza,rajendra shakyaRajendra Shakya,qiuzhi cindy cuiQiuzhi Cindy Cui,vesna milacicVesna Milacic,claudio n veraniClaudio N Verani,q ping douQ Ping Dou,

    The investigation of metal-based complexes with potential antitumor activity has been of paramount importance in recent years due to the successful use of cisplatin against various cancers. Gallium(III) and subsequently developed gallium(III)-containing complexes have shown promising antineoplastic effects when tested in a host of malignancies, specifically in lymphomas and bladder cancer. However, the molecular mechanism responsible for their anticancer effect is yet to be fully understood. We report here for the first time that the proteasome is a molecular target for gallium complexes in a variety of prostate cancer cell lines and in human prostate cancer xenografts. We tested five gallium complexes (1-5) in which the gallium ion is bound to an NN'O asymmetrical ligand containing pyridine and substituted phenolate moieties in a 1:2 (M/L) ratio. We found that complex 5 showed superior proteasome inhibitory activity against both 26S proteasome (IC50, 17 micromol/L) and purified 20S (IC50, 16 micromol/L) proteasome. Consistently, this effect was associated with apoptosis induction in prostate cancer cells. Additionally, complex 5 was able to exert the same effect in vivo by inhibiting growth of PC-3 xenografts in mice (66%), which was associated with proteasome inhibition and apoptosis induction. Our results strongly suggest that gallium complexes, acting as potent proteasome inhibitors, have a great potential to be developed into novel anticancer drugs.

    Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects. Publishing Authors By Initials

    d chenD Chen,m frezzaM Frezza,r shakyaR Shakya,qc cuiQC Cui,v milacicV Milacic,cn veraniCN Verani,qp douQP Dou,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Cancer research

    VOLUME: 67

    Page Numbers: 9258-65

    Journal Abbreviation: Cancer Res.

    ISSN: 0008-5472

    DAY: 1

    MONTH: Oct

    YEAR: 2007

    Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2984705

    Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects.

    AFFILIATION: The Prevention Program, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: 1R01CA120009

    ACRONYM: CA

    MEDLINETA: Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Inhibition of the proteasome activity by galliumIII complexes contributes to their anti prostate tumor effects Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News